0001945638-22-000002.txt : 20220909
0001945638-22-000002.hdr.sgml : 20220909
20220909171005
ACCESSION NUMBER: 0001945638-22-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220909
DATE AS OF CHANGE: 20220909
EFFECTIVENESS DATE: 20220909
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arsenal Biosciences, Inc.
CENTRAL INDEX KEY: 0001945638
IRS NUMBER: 824296120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-458499
FILM NUMBER: 221236830
BUSINESS ADDRESS:
STREET 1: 2 TOWER PLACE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 240-8844
MAIL ADDRESS:
STREET 1: 2 TOWER PLACE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001945638
Arsenal Biosciences, Inc.
2 TOWER PLACE
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
(650) 240-8844
DELAWARE
None
None
Corporation
true
2018
Kenneth
Drazan
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Beth
Seidenberg
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Director
Sean
Parker
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Director
Brook
Byers
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Director
Matthew
Fust
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Director
Margaret
Nibbi
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Valentin
Barsan
c/o Arsenal Biosciences, Inc.
2 Tower Place, Suite 700
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-02-10
false
true
false
0
230806614
220806682
9999932
Series B Preferred Stock, Series B-2 Preferred Stock and the respective common stock issuable upon conversion thereof.
false
17
0
0
0
false
Arsenal Biosciences, Inc.
/s/ Margaret Nibbi
Margaret Nibbi
Chief Legal Officer
2022-09-09